CRISPR-based system identifies important new drug targets in a deadly leukemia
Scientists at Cold Spring Harbor Laboratory (CSHL) have discovered a way to rein in an overactive protein that drives some aggressive leukemias. The renegade molecule, MEF2C, belongs to a class of proteins that is notoriously ...
Mar 8, 2018
0
22